A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...
New, improved formulation set to replace EGRIFTA SV®MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or ...
This case emphasises the need for early recognition and proper diagnosis of CHIKV infection in patients with acute joint pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results